Sitagliptin

Sitagliptin is a DPP‑4 inhibitor with modest HbA1c reduction and cardiovascular neutrality; it has no demonstrated heart failure outcome benefit. DPP-4 inhibitors may in fact exacerbate heart failure symptoms through oedema worsening. This is not the best drug for Mr. Green.

Please go back and re-consider. 

  • Matrița ADN, Primeri, ADN polimerază, dNTPs, Soluție tampon [undo]
  • Nitroglycerin [undo]
  • Prophase, prometaphase, metaphase, anaphase, telophase [undo]
  • He prefers to go for a walk. [undo]
  • Está enfadado. [undo]
  • Pe halat se pot transfera materiale periculoase în exteriorul laboratorului și se poate contamina zona [undo]
  • Η ποδιά εργαστηρίου μπορεί να μεταφέρει επικίνδυνα υλικά στον εξωτερικό χώρο και να μολύνει την περιοχή [undo]
  • Costas é o pai. [undo]
  • Descrierea 3 [undo]
  • PPIs are weak acids activated by protonation in parietal cells [undo]
  • Τον παρακολουθείτε για λίγες ώρες [undo]
  • Θεραπευτικές αποφάσεις [undo]
  • Nebulized ipratropium [undo]
  • Why constantly take my blood? I will simply reduce the dose and wait for improvement [undo]
  • Desnaturalización, Alineación, Extensión [undo]
  • Watch and wait until further testing is available [undo]
  • Serum potassium [undo]
  • Pioglitazone [undo]
  • Triplex αρτηριών κάτω άκρων [undo]
  • To avoid our Professor telling us off [undo]
  • Pentru a stabiliza structura dublei helixuri a ADN-ului, asigurând o scindare precisă [undo]
  • DNA Λιγάση [undo]
  • Βασίζομαι στα φυσικά χαρακτηριστικά [undo]
  • Μαγνητική τομογραφία (MRI) καρδιάς [undo]
  • Desnaturalización, Extensión, Alineación [undo]
  • Admission [undo]
  • Sitagliptin [undo]

Map: Michael Green_GEMD_2 (1116)
Node: 21125
Score:

reset

OpenLabyrinth
OpenLabyrinth is an open source educational pathway system

Review your pathway